Résultats de la recherche - R. N. Alyautdin

Annual meeting of representatives of National Pharmacovigilance Centers par R. N. Alyautdin

Connect to this object online.

PCSK9 Antagonists: Clinical Efficacy and Main Trends in the Development of New Medicines par A. A. Nekipelova, R. N. Alyautdin

Connect to this object online.

INVERSE AGONISTS: MORE THAN JUST ANTAGONISTS? par R. N. Alyautdin, B. K. Romanov

Connect to this object online.

Recommendations for evaluating the safety of medicinal products containing nanoparticles par R. N. Alyautdin, B. K. Romanov

Connect to this object online.

Dosis facit venenum par R. N. Alyautdin R.N, B. K. Romanov

Connect to this object online.

Transformation of views on the teratogenic effects of antiepileptic drugs par E. Yu, R. N. Alyautdin, B. K. Romanov

Connect to this object online.

The distribution of fullerene n anoparticles in the body in preclinical studies par R. N. Alyautdin, B. K. Romanov, V. A. Merkulov

Connect to this object online.

Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review) par N. Yu. Velts, O. V. Velts, R. N. Alyautdin

Connect to this object online.

NANOPARTICULATE BDNF AS A POTENTIAL ANTIDEPRESSANT VIA NEUROENDOCRINE MECHANISMS IN EXPERIMENTAL MODEL OF DEPRESSION par N.A.D. BINTI RAZLAN, M. KAPITONOVA, S.B. TALIP, N. RAMLI, I.B. BROHI, T.M. NWE, R.N. ALYAUTDIN, R.N. ALYAUTDIN

Connect to this object online.

Practical recommendations for screening of information on the drug safety par E. Yu. Pasternak, T. M. Bukatina, R. N. Alyautdin, B. K. Romanov

Connect to this object online.

Typical pharmacovigilance system master file (PSMF) par B. K. Romanov, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov

Connect to this object online.

ON THE QUESTION OF THE DEVELOPMENT OF FETAL CONGENITAL MALFORMATIONS IN THE CONDITIONS OF PREVENTIVE USE BY MOTHERS OF FOLIC ACID IN THE PERINATAL PERIOD par I. A. Toropova, R. N. Alyautdin, O. S. Alyautdina, B. K. Romanov

Connect to this object online.

Limits for the Content of Heavy Metals and Arsenic as a Means of Ensuring Safe Use of Herbal Medicinal Products par M. S. Galenko, I. V. Gravel, N. Yu. Velts, R. N. Alyautdin

Connect to this object online.

Rate Setting for Labour Costs Related to Pharmacovigilance System Inspections par M. Abdrakhmanov, R. N. Alyautdin, A. E. Krasheninnikov, B. K. Romanov

Connect to this object online.

Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results par Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin, S. V. Glagolev

Connect to this object online.

Guidelines for the planning and implementation of pharmacovigilance systems audit par S. V. Glagolev, Yu. V. Olefir, B. K. Romanov, R. N. Alyautdin

Connect to this object online.

Nicotine dependence and neuropsychotic effects of varenicline par T. M. Bukatina, A. S. Kazakov, R. N. Alyautdin, T. V. Romanova, I. I. Snegireva

Connect to this object online.

ON THE IMPACT OF DRUG NAMES AND LABELS ON THE RISK OF MEDICATION ERRORS par R. N. Alyautdin, A. P. Pereverzev, B. K. Romanov, N. D. Bunyatyan

Connect to this object online.

SGLT2 inhibitors: control of glycemia and nephroprotection properties par A. A. Volodin, M. L. Maximov, V. G. Slobodyan, R. N. Alyautdin

Connect to this object online.

On the safety of acetaminophen par R. N. Alyautdin, V. K. Lepakhin, B. K. Romanov, A. P. Pereverzev

Connect to this object online.